Clinical trial
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients…
NCT00394121 · SkyePharma AG, Industry · Completed
Key facts
| NCT number | NCT00394121 |
|---|---|
| Title | New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma |
| Official title | Long-term Open-label Safety Study With SkyePharma FlutiForm HFA pMDI (100/10 µg and 250/10 µg) in Adult and Adolescent Patients With Asthma |
| Lead sponsor | SkyePharma AG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Fluticasone propionate/formoterol fumarate |
| Enrollment | 400 |
| Start date | Mar 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Oct 31, 2006 |
| Last update posted | Aug 27, 2010 |
| Countries | Germany, Hungary, Poland, Romania, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: